Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Med Chem ; 26(24): 4573-4584, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30259803

RESUMO

BACKGROUND: The exploration of the plant biodiversity as a natural source to obtain sustainable food products and new bioactive pharmaceutical compounds has been growing significantly due to their abundance, safety and economy. Natural pharmaceutical and edible compounds present some advantages when compared to synthetic ones, such as being chemically inert and widely available. In this sense, plants of the genus Pereskia belonging to the Cactaceae family, have been studied. It is an unconventional wild edible plant that contains a large amount of protein and minerals. Studies have demonstrated their biological activities and potential application in different areas such as pharmaceutical, medicinal and food. OBJECTIVE: This review is focused on the chemical composition, functional properties, applications on pharmaceutical, nutraceutical and food areas and formulation techniques to enhance the stability and bioavailability of bioactive compounds from the underutilized wild edible plant known as ora-pro-nobis (Pereskia aculeata or Pereskia grandifolia). CONCLUSION: The latest studies involving ora-pro-nobis demonstrated its great potential due to its biological activities, which could stimulate further investigations. The utilization of this plant as a natural source to supplement the diet, or to prepare new food products and pharmaceutical formulations is an attractive approach to explore and fully realize the potential of the rich biodiversity found in Brazil and in other countries.


Assuntos
Cactaceae/química , Extratos Vegetais/química , Anti-Infecciosos/química , Anti-Infecciosos/farmacologia , Anti-Inflamatórios/química , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/farmacologia , Antioxidantes/química , Cactaceae/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Humanos , Folhas de Planta/química , Folhas de Planta/metabolismo
2.
Molecules ; 22(10)2017 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-29023400

RESUMO

A polyelectrolyte complex system of chitosan-pectin nano- and microparticles was developed to encapsulate the hormone insulin. The aim of this work was to obtain small particles for oral insulin delivery without chemical crosslinkers based on natural and biodegradable polysaccharides. The nano- and microparticles were developed using chitosans (with different degrees of acetylation: 15.0% and 28.8%) and pectin solutions at various charge ratios (n⁺/n- given by the chitosan/pectin mass ratio) and total charge. Nano- and microparticles were characterized regarding particle size, zeta potential, production yield, encapsulation efficiency, stability in different media, transmission electron microscopy and cytotoxicity assays using Caco-2 cells. The insulin release was evaluated in vitro in simulated gastric and intestinal media. Small-sized particles (~240-~1900 nm) with a maximum production yield of ~34.0% were obtained. The highest encapsulation efficiency (~62.0%) of the system was observed at a charge ratio (n⁺/n-) 5.00. The system was stable in various media, particularly in simulated gastric fluid (pH 1.2). Transmission electron microscopy (TEM) analysis showed spherical shape particles when insulin was added to the system. In simulated intestinal fluid (pH 6.8), controlled insulin release occurred over 2 h. In vitro tests indicated that the proposed system presents potential as a drug delivery for oral administration of bioactive peptides.


Assuntos
Quitosana/química , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos , Insulina/administração & dosagem , Nanopartículas/química , Pectinas/química , Eletricidade Estática , Células CACO-2 , Sobrevivência Celular/efeitos dos fármacos , Composição de Medicamentos , Liberação Controlada de Fármacos , Estabilidade de Medicamentos , Humanos , Nanopartículas/ultraestrutura , Tamanho da Partícula
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...